FGF-23 Là Một Bộ Điều Hòa Mạnh Mẽ Của Chuyển Hóa Vitamin D Và Cân Bằng Phosphate
Tóm tắt
Từ khóa
Tài liệu tham khảo
Quarles, 2001, Pathophysiology of X-linked hypophosphatemia, tumor-induced osteomalacia, and autosomal dominant hypophosphatemia: A perPHEXing problem, J Clin Endocrinol Metab, 86, 494, 10.1210/jcem.86.2.7302
Econs, 1994, Tumor-induced osteomalacia-unveiling a new hormone, N Engl J Med, 330, 1679, 10.1056/NEJM199406093302310
White, 2001, The autosomal dominant hypophosphatemic rickets (ADHR) gene is a secreted polypeptide overexpressed by tumors that cause phosphate wasting, J Clin Endocrinol Metab, 86, 497, 10.1210/jcem.86.2.7408
Larsson, 2003, Immunohistochemical detection of FGF-23 protein in tumors that cause oncogenic osteomalacia, Eur J Endocrinol, 148, 269, 10.1530/eje.0.1480269
Shimada, 2001, Cloning and characterization of FGF23 as a causative factor of tumor-induced osteomalacia, Proc Natl Acad Sci USA, 98, 6500, 10.1073/pnas.101545198
White, 2001, Autosomal-dominant hypophosphatemic rickets (ADHR) mutations stabilize FGF-23, Kidney Int, 60, 2079, 10.1046/j.1523-1755.2001.00064.x
Shimada, 2002, Mutant FGF-23 responsible for autosomal dominant hypophosphatemic rickets is resistant to proteolytic cleavage and causes hypophosphatemia in vivo, Endocrinology, 143, 3179, 10.1210/endo.143.8.8795
The ADHR Consortium, 2000, Autosomal dominant hypophosphatemic rickets is associated with mutations in FGF23, Nat Genet, 26, 345, 10.1038/81664
Yamazaki, 2002, Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets/osteomalacia, J Clin Endocrinol Metab, 87, 4957, 10.1210/jc.2002-021105
Jonsson, 2003, Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia, N Engl J Med, 348, 1656, 10.1056/NEJMoa020881
Bai, 2003, The autosomal dominant hypophosphatemic rickets R176Q mutation in FGF23 resists proteolytic cleavage and enhances in vivo biological potency, J Biol Chem, 278, 9843, 10.1074/jbc.M210490200
Bowe, 2001, FGF-23 inhibits renal tubular phosphate transport and is a PHEX substrate, Biochem Biophys Res Commun, 284, 977, 10.1006/bbrc.2001.5084
Yamashita, 2002, Fibroblast growth factor (FGF)-23 inhibits renal phosphate reabsorption by activation of the mitogen-activated protein kinase pathway, J Biol Chem, 277, 28265, 10.1074/jbc.M202527200
Kessler, 1978, A modified procedure for the rapid preparation of efficiently transporting vesicles from small intestinal brush border membranes. Their use in investigating some properties of D-glucose and choline transport systems, Biochim Biophys Acta, 506, 136, 10.1016/0005-2736(78)90440-6
Beck, 1998, Targeted inactivation of Npt2 in mice leads to severe renal phosphate wasting, hypercalciuria, and skeletal abnormalities, Proc Natl Acad Sci USA, 95, 5372, 10.1073/pnas.95.9.5372
Tenenhouse, 1999, Recent advances in epithelial sodium-coupled phosphate transport, Curr Opin Nephrol Hypertens, 8, 407, 10.1097/00041552-199907000-00003
Murer, 1996, Renal brush border membrane Na/Pi-cotransport: Molecular aspects in PTH-dependent and dietary regulation, Kidney Int, 49, 1769, 10.1038/ki.1996.264
Kempson, 1995, Parathyroid hormone action on phosphate transporter mRNA and protein in rat renal proximal tubules, Am J Physiol, 268, F784
Brown, 1999, Vitamin D, Am J Physiol, 277, F157
Segawa, 2002, Growth-related renal type II Na/Pi cotransporter, J Biol Chem, 277, 19665, 10.1074/jbc.M200943200
Nielsen, 2001, Expression of type III sodium-dependent phosphate transporter/retroviral receptor mRNAs during osteoblast differentiation, Bone, 28, 160, 10.1016/S8756-3282(00)00418-X
Shimada, 2002, Targeted ablation of FGF-23 causes hyperphosphatemia, increased 1,25-dihydroxyvitamin D level, and severe growth retardation, J Bone Miner Res, 17, S1;S168
Kahlen, 1994, Identification of a vitamin D receptor homodimer-type response element in the rat calcitriol 24-hydroxylase gene promoter, Biochem Biophys Res Commun, 202, 1366, 10.1006/bbrc.1994.2081